Ex parte NISHIOKA et al. - Page 3




              Appeal No. 1995-4623                                                                                         
              Application No. 07/918,588                                                                                   


                                            2                                                                              
                     O'Connor, S.D., et al.  (O'Connor) "Quenched Molecular Dynamics                                       
                     Simulations of Tuftsin and Proposed Cyclic Analogues", Journal of Medicinal                           
                     Chemistry, Vol. 35, No. 15, pp. 2870-2881 (1992).                                                     
                     The appealed claims stand rejected as follows: (1) Claims 1, 2, 4 and 5 under 35                      
              U.S.C. § 103 as unpatentable over the combined disclosures of Chipens (I) and                                
              Nikiforovich; (2) claims 1, 3, 4 and 6 under 35 U.S.C. § 103 as unpatentable over the                        
              combined disclosures of Chipens (I) and Hahn; (3) claims 1, 2, 4 and 5 under 35 U.S.C. §                     
              103 as unpatentable over Siemion or Stabinsky, either of those "primary references" in                       
              view of Chipens (II); and (4) claims 1 through 3 under 35 U.S.C. § 102(f) because                            
              applicants themselves did not invent the subject matter sought to be patented.                               
                     On consideration of the record, we shall not sustain these rejections.                                

                                                     SECTION 103                                                           
                     Having reviewed the Appeal Brief, Reply Brief, and Examiner's Answer, we                              
              conclude that the examiner's rejections under 35 U.S.C. § 103 are untenable.  Each                           

              appealed claim recites the pentapeptide cyclo[Thr-Lys-Pro-Arg-Gly] or                                        

              cyclo[Thr-Lys-Pro-Arg-Asp] fully cyclized in a "head-to-tail" manner, i.e., by coupling                      

              the alpha-amino group of theThr to the carboxyl group of Gly or Asp.  In our judgment,                       




                     2 O'Connor does not constitute a "prior art" reference because it was published two days after the    
              filing date of application no. 07/918,588, the application on appeal.                                        
                                                            3                                                              





Page:  Previous  1  2  3  4  5  6  7  8  9  Next 

Last modified: November 3, 2007